23andMe Will Resume Giving Health Data In The US
23andMe , a genetics examination society , has been afford the green light by the Food and Drug Administration ( FDA ) to resume providing U.S. customers with wellness selective information based on their DNA tests . The Silicon Valley - based biotech company wasforced to cease providing wellness datafrom personal genome examination after it fail to receive market authority from the FDA over headache that its result might be inaccurate ....